Follow
Ilan S. Schwartz
Title
Cited by
Cited by
Year
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ...
New England journal of medicine 383 (6), 517-525, 2020
15692020
Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial
CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ...
Annals of internal medicine 173 (8), 623-631, 2020
6432020
Emerging fungal infections: new patients, new patterns, and new pathogens
DZP Friedman, IS Schwartz
Journal of Fungi 5 (3), 67, 2019
2872019
Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)
KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ...
Open forum infectious diseases 7 (4), ofaa130, 2020
2392020
Re-drawing the maps for endemic mycoses
N Ashraf, RC Kubat, V Poplin, AA Adenis, DW Denning, L Wright, ...
Mycopathologia 185, 843-865, 2020
2052020
Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales)
K Dukik, JF Muņoz, Y Jiang, P Feng, L Sigler, JB Stielow, J Freeke, ...
Mycoses 60 (5), 296-309, 2017
1392017
Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International …
GR Thompson, T Le, A Chindamporn, CA Kauffman, ...
The Lancet Infectious Diseases 21 (12), e364-e374, 2021
1232021
Coronavirus disease 2019–associated invasive fungal infection
JW Baddley, GR Thompson III, SCA Chen, PL White, MD Johnson, ...
Open forum infectious diseases 8 (12), ofab510, 2021
1012021
High rates of influenza-associated invasive pulmonary aspergillosis may not be universal: a retrospective cohort study from Alberta, Canada
IS Schwartz, DZP Friedman, L Zapernick, TC Dingle, N Lee, W Sligl, ...
Clinical Infectious Diseases 71 (7), 1760-1763, 2020
962020
Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States
IS Schwartz, NP Wiederhold, KE Hanson, TF Patterson, L Sigler
Clinical Infectious Diseases 68 (2), 188-195, 2019
832019
Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis
Y Jiang, K Dukik, JF Muņoz, L Sigler, IS Schwartz, NP Govender, ...
Fungal Diversity 90, 245-291, 2018
832018
Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series
IS Schwartz, NP Govender, C Corcoran, S Dlamini, H Prozesky, R Burton, ...
Clinical Infectious Diseases 61 (6), 1004-1012, 2015
832015
Bacterial superinfections among persons with coronavirus disease 2019: a comprehensive review of data from postmortem studies
CJ Clancy, IS Schwartz, B Kula, MH Nguyen
Open Forum Infectious Diseases 8 (3), ofab065, 2021
812021
50 Years of Emmonsia Disease in Humans: The Dramatic Emergence of a Cluster of Novel Fungal Pathogens
IS Schwartz, C Kenyon, P Feng, NP Govender, K Dukik, L Sigler, Y Jiang, ...
PLoS pathogens 11 (11), e1005198, 2015
772015
Invasive mould disease in fatal COVID-19: a systematic review of autopsies
BE Kula, CJ Clancy, MH Nguyen, IS Schwartz
The Lancet Microbe 2 (8), e405-e414, 2021
742021
Outbreak Detection: First reported case of multidrug-resistant Candida auris in Canada
IS Schwartz, GW Hammond
Canada Communicable Disease Report 43 (7-8), 150, 2017
742017
Effects of sexual network connectivity and antimicrobial drug use on antimicrobial resistance in Neisseria gonorrhoeae
CR Kenyon, IS Schwartz
Emerging Infectious Diseases 24 (7), 1195, 2018
732018
Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis
RM Kariyawasam, TC Dingle, BE Kula, B Vandermeer, WI Sligl, ...
Clinical Microbiology and Infection 28 (7), 920-927, 2022
612022
Emergomyces: The global rise of new dimorphic fungal pathogens
IS Schwartz, NP Govender, L Sigler, Y Jiang, TG Maphanga, B Toplis, ...
PLoS Pathogens 15 (9), e1007977, 2019
612019
Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19
SM Lofgren, MR Nicol, AS Bangdiwala, KA Pastick, EC Okafor, ...
Open forum infectious diseases 7 (11), ofaa500, 2020
582020
The system can't perform the operation now. Try again later.
Articles 1–20